National Heart, Lung, and Blood Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2023-20491"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2023-20491"
section_name: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
positive_law: false
currency: "2023-09-21"
last_updated: "2023-09-21"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2023-20491"
document_type: "notice"
publication_date: "2023-09-21"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "88 FR 65182"
fr_volume: 88
---


#  National Heart, Lung, and Blood Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Institute Initial Review Group, Mentored Patient-Oriented Research Study Section, October 26, 2023, 10:00 a.m. to October 27, 2023, 6 p.m., National Institutes of Health, Rockledge 1, 6705 Rockledge Drive, Bethesda, MD 20892, which was published in the *Federal Register* on September 14, 2023, FR Doc 2023-19907, 88 FR 63115.

The National Heart, Lung, and Blood Institute Initial Review Group, Mentored Patient-Oriented Research Study Section meeting is being amended due to a change of the meeting time formats. The meeting will be held on October 26, 2023, from 9:00 a.m. to October 27, 6:00 p.m. This meeting will be a video assisted meeting, and closed to the public.

Dated: September 18, 2023.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.